NOVI METABOLIT HOLESTEROLA, 5-HOLESTEN, 3beta-25-DIOL, DISULFAT (25HCDS) ZA ZDRAVLJENJE METABOLNIH MOTENJ, HIPERLIPIDEMIJE, DIABETESA, BOLEZNI ZAMAŠČENIH JETER IN ATEROSKLEROZE
5-cholesten-3, 25-diol, disulfate (25HCDS) has been found to be an authentic PPAR ³ agonist and LXR antagonist, and is used for the therapy of lipid disorders and inflammatory diseases, including without limitation fatty liver, inflammatory bowel, and atherosclerotic diseases.